Ιατρική Ειδικότητα UEMS
Ψυχιατρική & Νευροανάπτυξη — Σελίδα 2
Formulation science addressing mental health: catecholaminergic modulation, ADHD, mood disorders, neuropsychological function, and the gut–brain axis as a therapeutic target.
25
φάκελοι
Δεν βρέθηκαν φάκελοι που να αντιστοιχούν στο επιλεγμένο θέμα MeSH σε αυτή τη σελίδα. Δοκιμάστε μια άλλη ετικέτα ή καταργήστε το φίλτρο.
Διαθέσιμη Προσαρμοσμένη Σύνθεση
Χρειάζεστε έναν Φάκελο για το Μόριό σας;
Project-specific requirements and next steps are confirmed in writing through the agreed scope.
RELATED RESOURCES
R&D Hub — All Scientific CategoriesFull library of evidence-based research covering formulation, bioavailability and clinical nutrition.EXPLORE ›Advanced Formulation Technology PlatformProject-specific formulation assessment, evidence review and regulatory pathway are defined in the agreed scope. Manufacturing arrangements and any external testing are confirmed per project.EXPLORE ›Production Formats & MOQ ReferenceHard capsules 150K, softgels 300K, sachets 75K — connect the science to actual industrial thresholds.EXPLORE ›Physician Supplement Brand Contract ManufacturingA project brief defines the formulation, evidence, regulatory path, scope and ownership terms before manufacturing is considered.EXPLORE ›Paid Discovery: R&D Due Diligence EntryTransform research findings into a scoped, confidential manufacturing brief.EXPLORE ›Commercialization Intelligence HubRegulatory and market strategy intelligence for supplement brand decision-makers.EXPLORE ›